Danielle Porter

机构：Mitchell Institute, Gilead Sciences (United States), Texas A&M University · ORCID：0000-0001-8459-2370

发表论文 113 篇 · 总被引 8824 次 · h-index 37

代表论文

• Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro (2023 · Scientific Reports · 被引 79)
• Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus (2024 · Science · 被引 42)
• A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant (2023 · The Journal of Heart and Lung Transplantation · 被引 38)
• Late remdesivir treatment initiation partially protects African green monkeys from lethal Nipah virus infection (2023 · Antiviral Research · 被引 35)
• Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1) (2023 · The Journal of Infectious Diseases · 被引 34)
• Effect of remdesivir post-exposure prophylaxis and treatment on pathogenesis of measles in rhesus macaques (2023 · Scientific Reports · 被引 15)